Please use this identifier to cite or link to this item:
|Title:||Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates|
|Authors:||Ma, X. |
Dihydrofolate reductase inhibitors
|Citation:||Ma, X., Woon, R.S.-P., Ho, P.C.-L., Chui, W.-K. (2009-09). Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates. Chemical Biology and Drug Design 74 (3) : 322-326. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1747-0285.2009.00860.x|
|Abstract:||Two triazaspirodienes, having similar phenoxy propyloxy side chain, were identified as potent mammalian dihydrofolate reductase inhibitors; one having a 6,5-spiro bicyclic ring system (IC50 = 2.3 nm) and the other a 6,6-spiro bicyclic system (IC50 = 6.9 nm). They also showed more than 50% antiproliferative activity against the MCF-7 breast cancer cells at 20 μm. This study demonstrated the potential lead of the diamino- triazaspirodienes in anticancer chemotherapeutical agents' discovery. © 2009 John Wiley & Sons A/S.|
|Source Title:||Chemical Biology and Drug Design|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 13, 2018
WEB OF SCIENCETM
checked on Jun 11, 2018
checked on May 4, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.